Jianerkang Medical Co.,Ltd. (SHA:603205)

Jianerkang Medical Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	1,051	1,024	1,046	1,034	1,093	782.04
Revenue Growth	4.36%	-2.04%	1.18%	-5.46%	39.79%	-51.83%
Gross Profit Gross Profit Growth	254.44	242.62	233.37	230.92	258.43	181.97
Operating Income Operating Income Growth	134.93	118.25	120.64	126.18	142.36	100.98
Net Income Net Income Growth	113.75	111.44	120.22	123.55	157.34	131.63
Earnings Per Share EPS Growth	0.72	0.71	0.97	1.05	1.34	1.13
EPS Growth	-16.02%	-26.80%	-7.95%	-21.64%	19.54%	-69.53%

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2025
Period Ending	Jun 30, 2026	Dec 31, 2025
China China Growth	114.16	114.16
Overseas Overseas Growth	910.23	910.23
Total Total Growth	1,024	1,024

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	799.38	764.91	721.81	226.24	178.25	97.8
Total Debt Total Debt Growth	18.18	21.76	-	-	30.04	50.05
Net Cash (Debt) Net Cash Growth	781.2	743.15	721.81	226.24	148.21	47.75
Net Cash Growth	3.35%	2.96%	219.05%	52.65%	210.40%	89.99%
Net Cash Per Share Net Cash Per Share Growth	4.94	4.73	5.82	1.93	1.27	0.41

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	162.83	158.79	141.1	157.8	163.01	70.6
Capital Expenditures CapEx Growth	-91.05	-69.98	-39.75	-84.18	-66.32	-48.64
Free Cash Flow Free Cash Flow Growth	71.78	88.81	101.35	73.62	96.7	21.96
Free Cash Flow Growth	-25.33%	-12.38%	37.66%	-23.86%	340.34%	-94.07%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	24.20%	23.69%	22.32%	22.34%	23.64%	23.27%
Operating Margin	12.83%	11.54%	11.54%	12.21%	13.02%	12.91%
Pretax Margin	12.26%	12.34%	13.17%	13.80%	16.27%	19.13%
Profit Margin	10.82%	10.88%	11.50%	11.95%	14.39%	16.83%
FCF Margin	6.83%	8.67%	9.69%	7.12%	8.85%	2.81%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct 8, 2026	Dec 31, 2025	Dec 31, 2024
Dividend Per Share Dividend Per Share Growth	0.250	0.250	0.351
Dividend Per Share Growth	0%	-28.78%	-
Dividend Yield	1.15%	0.89%	1.22%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 8, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	30.22	40.02	38.21	-	-	-
P/FCF Ratio	47.25	50.22	45.32	-	-	-
PS Ratio	3.23	4.35	4.39	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 3, 2026

Data Sources Report a data error